Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

New cytokine-targeted therapies show promise for treating alopecia areata.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Upadacitinib may effectively treat alopecia areata without side effects.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Recent advances in hair loss treatments show significant progress.

Ruxolitinib treatment may cause eyelash growth.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

People with alopecia areata may have a higher risk of blood clots.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

New treatments for hair loss show promise, but require more research on long-term effects and proper dosing.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.